as of 12-05-2025 3:46pm EST
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
| Founded: | 2008 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 879.2M | IPO Year: | 2019 |
| Target Price: | $17.00 | AVG Volume (30 days): | 568.8K |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.21 | EPS Growth: | 20.42 |
| 52 Week Low/High: | $13.14 - $19.78 | Next Earning Date: | 11-05-2025 |
| Revenue: | $364,494,000 | Revenue Growth: | -13.98% |
| Revenue Growth (this year): | -4.27% | Revenue Growth (next year): | 3.76% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See how INMD stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "INMD InMode Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.